News & Media: All

Jul 24, 2017

PHE Researchers Publish New Study Comparing Clinical Trial Efficacy and Real-World Effectiveness for Cancer Therapies

A new study by PHE researchers recently published in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), examines the relationship between the efficacy of randomized controlled trials (RCTs) and real-world effectiveness for onco ...

Jul 21, 2017

Managed Healthcare Connect Presents Details of New PHE RA Study

Christina Vogt with Managed Healthcare Connect recently provided a breakdown and analysis of a new PHE study on the impact of ACPA status on patient costs associated with rheumatoid arthritis.

Published in the Journal of Managed Care Pharmacy, the study demonstrated that patients with rheum ...

Jul 21, 2017

Jena Discusses New PHE Preeclampsia Study with Orlando Sentinel

PHE Scientific Advisor Anupam Jena, coauthor of a new study on preeclampsia in the September issue of American Journal of Obstetrics & Gynecology, discussed the study’s findings and the growing economic impact of the condition with the Orlando Sentinel’s Amelia Cheatham.

The study by Jena ...

Jul 17, 2017

Study by Precision’s Sharma Named as One of Five Most Influential Articles of 2016

Precision would like to congratulate Abhishek Sharma, Associate Health Economist, Evidence Strategy & Generation, for his outstanding work as coauthor of an article appearing in the Journal of Pharmaceutical Policy and Practice, named one of their five most influential articles of 2016.

The fi ...

Jun 20, 2017

Precision’s Goldman and Lakdawalla in WSJ: Look to Major League Baseball for Drug Pricing Insight

In a new commentary appearing in The Wall Street Journal, Precision Health Economics cofounders Dana Goldman and Darius Lakdawalla turn to the national pastime to provide a fresh perspective on the issue of drug pricing and the return on investment pharmaceutical companies need to sustain innova ...

Jun 19, 2017

Maclean Talks Payer Access and New Opportunities Arising From Cures 3037

During the recent ISPOR conference, Ross Maclean, Precision Health Economics' SVP, Head of Medical, sat down to talk with Med Ad News’ Christiane Truelove on new opportunities for payer access in light of new FDA draft guidance around section 3037 of the 21st Century Cures Act. While Maclean ...

Jun 9, 2017

Jason Shafrin's Blog Named to Top 100 Economics Blogs of 2017 List

For the second year in a row, Precision Health Economics Senior Research Economist Jason Shafrin’s blog, “Healthcare Economist,” has been named by Intelligent Economist to their list of Top 100 Economics Blogs (worldwide). Jason’s blog is listed first in the economic blogs category, ...

Jun 8, 2017

Goldman and Jena Discuss the Challenges of Value-Based Pricing in STAT News

In a new commentary for STAT News, PHE co-founder Dana Goldman and scientific advisor Anupam Jena discuss the advantages of value-based pricing, pointing out several of the key challenges that complicate the application of health technology assessments. Goldman and Jena make the case that more t ...

Jun 2, 2017

PHE's Lakdawalla in LA Times: Providing Perspective on California's Proposed Single-Payer Plan

PHE Co-founder and Chief Scientific Officer Darius Lakdawalla speaks with Melanie Mason from The Los Angeles Times in a new Q&A, discussing the implications of California's new legislation favoring a single-payer healthcare system.

To read the complete article, please click here.

Jun, 2017

Schafer, Galante, and Shafrin in JMCP: New Precision Survey Provides Insight Into Payer Use of Value Tools

In the current supplemental issue of Journal of Managed Care & Specialty Pharmacy (JMCP), Precision’s Jeremy Schafer, Dominic Galante, and Jason Shafrin share results of a recent survey of payers discerning payers’ use of value tools in healthcare decision-making.

Deploying Precision for ...

May 23, 2017

PHE's Baumgardner Participates in Becker Friedman Institute Health Care Reform Panel

On May 22nd, PHE Senior Research Economist James Baumgardner was an invited panelist for The University of Chicago's Becker Friedman Institute for Research in Economics. On the panel, titled "The Economic Consequences of Health Care Reform," James applied his past experience as a 20-year veteran ...

May 19, 2017

Precision’s Abhishek Sharma Selected for World Heart Federation’s Emerging Leaders Program

Congratulations to Associate Health Economist Abhishek Sharma, part of Precision Health Economics’s Evidence Strategy, Generation, and Communications team, for his acceptance into the World Heart Federation’s Emerging Leaders (EL) program. The program is part of a WHF initiative to reduce ...

May 18, 2017

PHE's Bringing Our Best and Brightest to ISPOR

ISPOR's 22nd Annual International Meeting is almost here- May 20th-May 24th, 2017- and Precision Health Economics will have a very prominent presence!  

With over 25 of our experts in attendance, PHE thought leaders will be participating in a variety of scientific presentations, including a Ple ...

May 18, 2017

PHE's Seabury and Sood Promote Development of Antimicrobial Drugs in Health Affairs Blog Commentary

As global health leaders gather in Berlin from May 19-20 for the first-ever G20 Health Ministers’ meeting, one of the main topics of discussion is expected to be how to best fight the threat of antimicrobial resistance (AMR). In a new Health Affairs blog post, PHE scientific advisors Seth Sea ...

May 15, 2017

Lakdawalla, Bhattacharya and Malani in The Conversation: America Needs A ‘Do-Over’ on Medicaid Reform

PHE’s Darius Lakdawalla, along with co-authors Jay Bhattacharya and Anup Malani, offer a new commentary in The Conversation, making the argument that Medicaid reform is drastically needed and that the best ideas representing both government-administered health insurance and market-based healt ...

May 8, 2017

Lakdawalla's ACO & Emerging Healthcare Delivery Coalition Keynote Summarized by AJMC

In a new article appearing on the AJMC's website, Mary Caffery summarizes Darius Lakdawalla's recent keynote presentation at the AJMC's ACO & Emerging Healthcare Delivery Coalition.

To read the complete article, please click here.

May 5, 2017

PHE’s Stevens and Chou Address Variations in Cost-Effectiveness Studies of PCSK-9 Inhibitors in New Commentary for Journal of Medical Economics

PHE’s Warren Stevens and Jacquelyn Chou, along with coauthor Peter Toth, examine the markedly different cost-effectiveness study results for PCSK-9 inhibitors in a new commentary in the Journal of Medical Economics. The authors attribute the differences primarily to variations in assump ...

May 3, 2017

PHE Paper Selected As Value in Health Editor's Choice Article

We are proud to announce that a recently published paper with PHE co-authors, “Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations,” has been selected to be an Editors’ Choice article in the June 2017 issue of Value in Health.

To see the complete article as it ...

May 2, 2017

PHE's ESGC Provides Critical Support to New Legislation, FDA Guidelines

Congratulations to Precision Health Economics, and in particular the Evidence Strategy, Generation, and Communication (ESGC) practice group, for their outstanding efforts in support of the development of new legislation and FDA guidelines allowing biopharmaceutical manufacturers to more proactiv ...

Apr 28, 2017

PHE's Lakdawalla to Deliver Keynote Presentation at AJMC's ACO & Emerging Healthcare Delivery Coalition

PHE Chief Scientific Officer Darius Lakdawalla will deliver the keynote presentation at the AJMC's ACO & Emerging Healthcare Delivery Coalition, to be held May 4th-5th in Scottsdale, Arizona. Dr. Lakdawalla's keynote, to be presented on May 5th, will focus on value frameworks, and provide an eco ...

Apr 27, 2017

Precision’s Blandford in STAT First Opinion: The time for expansion of value-based drug reimbursement is now

Precision’s Larry Blandford offers a new commentary in STAT First Opinion, insisting that payers and the pharmaceutical industry come together to develop a value-based drug reimbursement system. He suggests taking a page from the playbook developed for electronic prescribing as the key to mov ...

Apr 14, 2017

Neumann and Baumgardner in Health Affairs: Balance Needed in Cost-Effectivness Analysis

In a new blog commentary for Health Affairs, PHE's Peter Neumann and James Baumgardner examine the reasons why application of CEA technologies across different types of healthcare interventions are imbalanced, and suggest some possible ways in which the policies of government and private entitie ...